データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Insulet Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk.
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Executive VP Of Insulet Sold 26% Of Their Shares
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
Insulet Is Maintained at Overweight by JP Morgan